• Company
• Phesgo can be prescribed in Korea with reimbursement
• by Eo, Yun-Ho Sep 30, 2024 05:46am

• Company
• K-Phama companies are targeting Southeast Asia
• by Heo, sung-kyu Sep 27, 2024 05:53am

• Company
• 'Treatment options for psoriasis are evolving'
• by Son, Hyung Min Sep 27, 2024 05:53am

• Company
• KRPIA expresses concerns over drug approval fee hike
• by Eo, Yun-Ho Sep 27, 2024 05:53am

• Company
• Switching between JAKis for RA yet to be reimbursed
• by Eo, Yun-Ho Sep 27, 2024 05:52am

• Company
• Minjung Jung to head Corporate Affairs at Sanofi KR, NZ, AU
• by Eo, Yun-Ho Sep 26, 2024 05:51am

• Company
• "Bird flu: a new emerging pandemic risk factor"
• by Son, Hyung Min Sep 25, 2024 05:49am

• Company
• ‘Link the processes to improve access to orphan drugs'
• by Kim, Jin-Gu Sep 25, 2024 05:49am

• Company
• Cancer mRNA vaccine shows potential in brain tumor
• by Son, Hyung Min Sep 24, 2024 05:46am

• Company
• 'Keytruda' attempts at reimbursement for TNBC
• by Whang, byung-woo Sep 24, 2024 05:46am